EPS Highlights: Illumina (ILMN) a Juggernaut, Gilead Sciences (GILD) a Blowout, Boeing (BA) a Behemoth

April 23rd, 2014

Courtesy of Briefing.com Illumina (ILMN) Illumina beats by $0.02, beats on revs; guides FY14 EPS above consensus, revs above consensus (147.98 +6.77) : Reports Q1 (Mar) earnings of $0.46 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.44; revenues rose 27.2% year/year to $421 mln vs the $391.66 mln [...]

Cause For Concern: Triple Whammy Shocker: Goldman Shutting Down Sigma X?

April 9th, 2014

Courtesy of Zero Hedge Back on March 21, before the release of Michael Lewis’ Flash Boys and before the infamous 60 Minutes interview, when Goldman COO Gary Cohn wrote his infamous WSJ Op-ed bashing HFT, it was clear that something was afoot. That something became promptly clear when it was revealed that Goldman is among the [...]

Stocks to Watch: InterMune (ITMN) and Another Gold Mining Takeover Bid Allied Nevada (ANV)

January 14th, 2014

ITMN,ANV ITMN InterMune target raised to $22 at Canaccord Genuity; healthy Esbriet revenue growth but focus remains on upcoming ASCEND and Bi phase 3 trials (17.2461 +0.1461) Canaccord Genuity raises their ITMN tgt to $22 from $17 on higher chance of ASCEND success; continuing EU Esbriet growth. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis [...]

Stocks To Watch: ISIS Pharm.(ISIS), Tekmira (TKMR), Osisko Mining (OSK.TO)

January 13th, 2014

ISIS ISIS Pharm announces positive decision on European Orphan Drug Designation for ISIS-APOCIII Rx (47.60 ) Co announced that the Committee for Orphan Medicinal Products (COMP) has issued a positive opinion for Orphan Drug Designation for ISIS-APOCIIIRx for the treatment of patients with familial chylomicronemia syndrome (FCS). TKMR Tekmira Pharma (halted) signs development agreement with [...]

Stock Market Strategy: Inflation Rate Not Just Employment Key Factor For The Fed in 2014

January 9th, 2014

Courtesy of Bill Gross (PIMCO) “I am amazed at the fascination and emphasis placed on the u-rate during employment Fridays. Bond prices will move (in some cases by points) with a minor up or down change in unemployment relative to expectations, but when it comes to the third little pig of the litter – inflation [...]

Stocks to Watch: Micron (MU) EPS Strong, Microsoft (MSFT) CEO Search, Seattle Genetics (SGEN) Expands Collaboration with AbbVie (ABBV)

January 8th, 2014

MU,SGEN,MSFT,ABBV MU Micron: Color on qtr (21.73 ) Needham raises its MU tgt to $34 from $30 after Co reported its F1Q14 (Nov) results, the first full qtr with the combined MU and Elpida results. The results handily beat both its ests and the Streets thanks to continued favorable supply and demand dynamics in the [...]

Stock Market Strategy: 2013 Year End Review

December 27th, 2013

It is time to take stock of where we are, how we got here and where are we going I often remind myself that the key to financial success over the long term is the ability to make only a relatively few correct decisions.  For example we accurately saw an approaching financial storm in late 2007 and structured our portfolio [...]

Credit Update: Taper Not Likely According to CDS

December 18th, 2013

Courtesy Of MJ the Credit Guru If the FOMC was to initiate tapering its bond purchases today the credit markets appear as if they will be completely offsides. The credit markets have not been offsides many times in the last 5-6 years. US Money Center Bank CDS spreads are near their tightest levels in years. [...]

2014 Outlook: Credit Spreads Tighter, S&P 500 Higher and Europe to Outperform

December 12th, 2013

Courtesy of M.S. Howell and Co. Investor decisions to add leveraged credit risk to their portfolios through CMOs, CLOs and CDOs does not mean the current credit market cycle is reversing. The current credit cycle will reverse when underlying credit fundamentals deteriorate to a point that causes investors to abandon CMOs, CLOs and CDOs.  [...]

Credit Update: No Taper in December

December 11th, 2013

Courtesy of MJ the Credit Guru We believe credit market index and Financial Sector spread performance do not indicate that the market has discounted tapering…but that it does not expect tapering to happen in 2013. European Markets sent credit spreads wider the day the USA was eating its Thanksgiving Day turkey. The US credit markets [...]